TANG PRIZE/Tang Prize laureate happy his research may save COVID-19 patients
06/19/2020 10:43 PM
Japanese immunologist Kishimoto Tadamitsu, one of the co-winners of the 2020 Tang Prize in biopharmaceutical science, was very happy that his early research has shown potential in saving COVID-19 patients from dying due to complications.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in TANG PRIZE
- Tang Prize laureates awarded Nobel honor for mRNA vaccine researchThe Nobel Prize in Physiology or Medicine has been awarded this year to two Tang Prize laureates for their work on developing the technology that led to the mRNA vaccines against COVID-19, the Tang Prize Foundation said Monday.10/02/2023 10:04 PM
- Tang Prize laureate lauds vaccines, slams anti-vax activismVaccines save more lives than any other treatment, messenger RNA (mRNA) pioneer and Tang Prize winner Drew Weissman said Wednesday, adding that although anti-vax sentiment was not new, the fact it had recently snowballed into a wider political issue was concerning.08/02/2023 09:59 PM
- Tang Prize laureate calls for actions to 'regenerate democracy'Action is required to "regenerate democracy" amid a sense of "tiredness" and "complacency" from voters toward the political system, Tang Prize laureate and laureate professor emeritus at the University of Melbourne Cheryl Saunders said Wednesday in Taipei.08/02/2023 09:02 PM
Latest
- Society
Taiwan headline news
04/26/2024 11:58 AM - Business
U.S. dollar down in Taipei trading
04/26/2024 10:39 AM - Business
Taiwan shares open higher
04/26/2024 09:19 AM - Society
Government platform touts 60-80% reduction in statutory animal testing
04/25/2024 10:58 PM - Society
Traffic controls to be enforced at Taipei rallies Saturday
04/25/2024 10:43 PM